Pro: Quite positive on Mylan's trajectory

In this video

Share

Pro: Quite positive on Mylan's trajectory

Discussing Mylan's EpiPen profit calculations and how to view the stock, with Ronny Gal, Sanford Bernstein Senior Analyst.
02:06
Mon, Sep 26 20162:20 PM EDT